Navire Pharma is developing SHP2 inhibitors as effective additions to the therapeutic arsenal for difficult-to-treat cancers.
Agiliti
7 followers
Bristol-Myers Squibb
291 followers
AtriCure
4 followers
DM Clinical Research
18 followers
Apollo Global Management
58 followers
Astellas Pharma
49 followers
NYU Langone Health
38 followers
Abbott
425 followers
Cosette Pharmaceuticals
1 follower
West Pharmaceutical Services
11 followers
Merck
318 followers